3-Fluoromethcathinone
| 3-Fluoromethcathinone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
3-Fluoromethcathinone (also known as 3-FMC) is a synthetic stimulant of the cathinone class. It is a fluorinated derivative of methcathinone, which is a beta-ketone analogue of methamphetamine.
Chemical structure and properties
3-Fluoromethcathinone is chemically similar to methcathinone, with the addition of a fluorine atom at the third position of the phenyl ring. This modification is thought to influence its pharmacological properties, potentially altering its potency and duration of action.
Pharmacology
3-FMC acts as a central nervous system stimulant. It is believed to exert its effects by increasing the levels of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. This is achieved through the inhibition of their reuptake into neurons, similar to other stimulants in the cathinone class.
Effects
The effects of 3-Fluoromethcathinone are reported to be similar to those of other stimulants, including increased alertness, euphoria, and sociability. However, the specific effects can vary depending on the dose, route of administration, and individual tolerance.
Legal status
The legal status of 3-FMC varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. In others, it may be unregulated or fall under analogue laws.
Safety and toxicity
The safety profile of 3-Fluoromethcathinone is not well-established, and its use is associated with potential risks. Adverse effects may include cardiovascular issues, anxiety, insomnia, and addiction. Due to the lack of comprehensive studies, the long-term effects of 3-FMC use remain unknown.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian